ExSight Ventures

Investor type

VC

Founded

2014

AUM

-

Location

New York, New York, United States

Investment Ticket

$0-1 m

Investment Stage

Pre-seed Seed Series A Series B

Region of investment

North America Europe Asia
Investor profile last updated: 21 July, 2026

Profile

ExSight Ventures is a venture capital firm based in the United States, specializing in early-stage investments in the life sciences sector, particularly in ophthalmic companies. The firm was founded by two accomplished retinal surgeons who leverage their in-depth knowledge and networks within the field to guide investment decisions. ExSight Ventures is noted for its strategic focus on ophthalmology, differentiating itself through a combination of domain-specific expertise and a mission-focused approach to investing in innovative diagnostic and treatment solutions for eye conditions.

The firm invests in biotechnology, medical devices, pharmaceuticals, and software that have applications within ophthalmology. ExSight Ventures targets investment rounds from pre-seed to Series B, where its capital, along with advisory and industry insights, can significantly impact the development and success of its portfolio companies. The firm's commitment to early-stage life sciences is complemented by its capital-efficient investment strategies, aimed at maximizing value creation. The firm does not have a public record of total AUM or detailed fund histories available.

Notable portfolio companies of ExSight Ventures include a selection focused on vision and ophthalmology-related breakthroughs. Due to the firm's concentrated focus, these companies typically reflect innovative advancements within the sector, although specific company names were not prominently listed on the website.

Industry

Infrastructure Life Sciences MedTech AI Software Pharmaceuticals Medical Devices Healthcare Services Biotechnology HealthTech

Contacts

Name
Title
Email
avatar
Maneesha Ghiya Partner and Co-Founder
Partner and Co-Founder
-
avatar
Alan Spiro Partner
Partner
-
Upgrade to see contacts
avatar
PCA5yDi3xu1cN2z8 PCA5yDi3xu1cN2z8
PCA5yDi3xu1cN2z8
avatar
PCA5yDi3xu1cN2z8 PCA5yDi3xu1cN2z8
PCA5yDi3xu1cN2z8
avatar
PCA5yDi3xu1cN2z8 PCA5yDi3xu1cN2z8
PCA5yDi3xu1cN2z8
Investment-team contacts for ExSight Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about ExSight Ventures

ExSight Ventures is a venture capital firm. It backs companies at Pre-seed, Seed, Series A and Series B, writing tickets of $0-1 m.
ExSight Ventures is located in New York, New York, United States.
ExSight Ventures was founded in 2014.
ExSight Ventures invests in companies and startups in Infrastructure, Life Sciences, MedTech, AI, Software, Pharmaceuticals, Medical Devices, Healthcare Services, Biotechnology, HealthTech.
ExSight Ventures invests in companies and startups in North America, Europe, Asia.
ExSight Ventures invests in companies and startups at Pre-seed, Seed, Series A, Series B.
ExSight Ventures usually invests $0-1 m on average.
ExSight Ventures can be reached through its website exsightventures.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for ExSight Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query ExSight Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 July, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.